Working… Menu

A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva (LUMINA-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03188666
Recruitment Status : Completed
First Posted : June 15, 2017
Last Update Posted : October 6, 2021
Information provided by (Responsible Party):
Regeneron Pharmaceuticals